Q1 2025 preliminary net sales rise 7% CER and adjusted diluted EPS results of at least $0.55 CER both above outlook despite challenging macro environment Full-year 2025 adjusted diluted EPS outlook ...
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention
Ethris, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and Lonza, one of the world's largest contract development and manufacturing organizations ...
Dr Ting-Yu Lin and Dr Francesco Boselli of our Department of Biosciences have each been granted a Springboard Award to help ...
Awarded by the Academy of Medical Sciences in partnership with the Government’s Department for Science, Innovation and Technology, Wellcome, and the British Heart Foundation, the Springboard Award ...
Scientists at the University of Iowa have made an exciting discovery that could lead to new cancer-fighting drugs. They found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback